Regen BioPharma Inc (RGBP)

[cvinvestor]

I concur. Intent of this PR is to lay out programs and $$$ needed, to the tune of $4.5M to bring currently advanced products to clinical trials. They are really keeping a lid on the HemaX Mexico results, only stating that no adverse effects have been seen.

Wish they would give more timeframes as to resolution of things like ODD for HemaX rather than just saying they are responding to FDA (since it was filed in January, what needs to be done after 6 months?)

This PR may be for the purpose of drawing interest or it may be for the purpose of laying out the financial needs before releasing a PR about their arrangements for funding through BA Securities, I don't know.

Nice to have a summary and the $ amounts. Other than that as new, we have Q4 2016 clearance for expanded HemaX (which would be great if it happens and trials actually start).

Resubmitting dCellVax in Q3 for metastatic breast cancer - nice to know, not much as to the why. What happened to the resubmission of dCellVax data from Kesari testing? Why don't we know what has happened (good or bad).

tCellVax aimed to start 2017, but don't know what quarter, so not much help there.

Nice PR to have, but still too much generalities and not enough specifics along the road as to the what and why of progress. Without the specifics and news of testing results on regular updates, hard road to draw in interest, but hopefully that will be going on behind the scenes.